IFN-gamma release assays in tuberculosis management in selected high-risk populations. - Wikidata - wikimedia - TriplyDB

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

http://www.wikidata.org/entity/Q37418061

about

HIV and Tuberculosis: a Deadly Human Syndemic Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons.Recent advances in testing for latent TB.Gamma Interferon Assays Used in the Diagnosis of Tuberculosis.Comparative utility of cytokine levels and quantitative RD-1-specific T cell responses for rapid immunodiagnosis of tuberculous meningitis.Psoriatic disease and tuberculosis nowadays.

P2860

Q30052157-CEA93E37-88B5-4631-8F68-B5290100FA7E Q34097352-9AD27FAF-D919-4D43-8D0E-D39A779A7345 Q34386405-983AAE49-1AF5-4905-879E-02D8D89DA850 Q34478200-CE700DF4-652F-4CD1-AB2F-6FFD59583E64 Q35530464-57CE393D-CB66-4187-BA7D-EB692CD13759 Q35974892-ED8A4E93-5B04-4E7F-BF1D-07C04CE2E0C3

P2860

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

http://www.wikidata.org/entity/Q37418061

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

@en

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

@nl

type

label

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

@en

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

@nl

prefLabel

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

@en

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

@nl

P1433

Q37418061-11A08250-F070-4B23-84E2-8841D58FB1A2

P1476

Q37418061-B23FFFDA-1475-49D4-8A92-3F508382CDE3

P2093

Q37418061-14EAB8E9-3A30-42C4-BC88-336323CCF3A7

Q37418061-32FE6D9A-6B36-4439-B5B1-ECF29A74F3AD

Q37418061-34275726-85A8-4CE9-B89A-A840ED26CD1C

Q37418061-A820A03C-285F-448D-A0FE-3488ED05808D

Q37418061-F71F315B-E76D-466E-9960-3F2E6498A99C

P2860

Q37418061-09B79DB1-040B-4303-9413-1CA3A32D28E7

Q37418061-11CE25F2-87B6-4C17-8771-63A7063F796C

Q37418061-16A07BAD-A6BF-444C-94CF-5676802DC037

Q37418061-1774A209-8487-4149-9F40-FD24877D2ABE

Q37418061-192A349C-1B0C-4455-81F8-DC9D1EC265D3

Q37418061-1C0577C4-6396-4F59-AD72-FD7BAF16DB42

Q37418061-1CBDD347-5C93-4361-96B1-9699B29C8BDC

Q37418061-1D17D7EB-DA66-47F7-808D-316928EAE41E

Q37418061-1D497D83-8DAB-46F7-9103-5BDD9999B201

Q37418061-20BCBF29-4535-400F-B323-95D9B6C45BDE

P304

Q37418061-B4E10953-3638-4C84-8838-FA29D047287C

P31

Q37418061-AA0059C4-E216-4176-982D-E620C9725B9E

P356

Q37418061-018558A1-D3AB-449B-973F-1CE9EDF2C72B

P433

Q37418061-FC34C540-DF16-431D-81D7-5CC58F03202A

P478

Q37418061-83BF9D4B-9E40-4364-8DDB-E4704E3F0647

P577

Q37418061-3D9BAB83-D639-4B32-8A56-124425142992

P698

Q37418061-395D3C9F-4B18-4C95-92DD-A476BCFF706F

P921

Q37418061-520A9455-A1EA-4E31-B2E1-D9C1ECBF8B06

P356

14737159.9.2.165

P1433

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

P1476

IFN-gamma release assays in tuberculosis management in selected high-risk populations.

@en

P2093

Alessandro Matarese

http://www.w3.org/2001/XMLSchema#string

Alessandro Sanduzzi

http://www.w3.org/2001/XMLSchema#string

Barbara Bellofiore

http://www.w3.org/2001/XMLSchema#string

Domenico Galati

http://www.w3.org/2001/XMLSchema#string

Marialuisa Bocchino

http://www.w3.org/2001/XMLSchema#string

P2860

Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa

A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?

Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis

Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice

Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts

Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression.

T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.

The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.

P304

165-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737159.9.2.165

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19298140

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde